Subject: RE: COVAX Shareholders Council, Thursday 18 March, 13.00-15.00 CET - Materials and Logistics
From: Brenda Killen <[email-masked]>
To: "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, Anne Weber <[email-masked]>, "[email-masked]" <
Cc: "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>, Omar Abdi <[email-masked]>, Etleva Kadilli <[email-masked]>, Benjamin Schreiber <[email-masked]>, Dr Zsuzsanna Jakab <[email-masked]>, "O'BRIEN, Katherine" <[email-masked]>, Lidija Kamara - WHO <[email-masked]>, mpate <[email-masked]>, Michael Kent Ranson <[email-masked]>, Diane Wu <[email-masked]>, Clementine Laurence Murer <c
Date: Wed, 17 Mar 2021 20:55:45 +0000

Dear Shareholders Council Members

We are pleased to confirm that the pre-read for the meeting is now available in Arabic, French, Russian and Spanish on BoardEffect at
https://gavi.boardeffect.co.uk/workrooms/14276/books/10056836.

Regards

Brenda

From: Brenda Killen

Sent: 11 March 2021 23:05

To: [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]

Cc: [email-masked]; [email-masked]; [email-masked]; [email-masked]; Omar Abdi ; Etleva Kadilli ; Benjamin Schreiber ; Dr Zsuzsanna Jakab ;
O'BRIEN, Katherine ; Lidija Kamara - WHO ; mpate ; Michael Kent Ranson ; Diane Wu ; Clementine Laurence Murer ; [email-masked]; Maty
Dia ; [email-masked]; Amy Whalley ; [email-masked]; Muluken Desta ; Dr. Daniel Gebremichael ; [email-masked]; Grata Endah Werdaningtyas
; Meutia H. Hasan ; Executive Team ; Executive Team Assistants ; Governance Staff ; Executive Office Staff
; COVAX Facility Leadership team ; COVAX Facility ; Daniel Thornton ; Sam Muller ; Gloria Kebirungi ; Carmen
Tull ; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; Lene Lothe ; [email-masked]; [email-masked]; [email-masked]; Amy Whalley ;
[email-masked]; [email-masked]; [email-masked]; [email-masked]; Gian Gandhi ; Dorcas Noertoft ; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; Assietou Diouf ; Ian MacTavish (Consultant)
; Thabani Maphosa ; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; Anne Weber ; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; Lene Lothe ; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked]; [email-masked];
[email-masked]

Subject: COVAX Shareholders Council, Thursday 18 March, 13.00-15.00 CET - Materials and Logistics

Dear Shareholders Council Members

I am pleased to confirm that
the pre-read for the meeting of the COVAX Shareholders Council
which will take place on Thursday 18 March from 13.00 to 15.00 Geneva time, is
now available for you to consult and download on BoardEffect at
https://gavi.boardeffect.co.uk/workrooms/14276/books/10056836

We would kindly request that you share the materials within your country/economy/organisation/constituency as appropriate, as per the information I shared with you in relation to the BoardEffect platform earlier today.

In respect of Agenda Item 3, the latest COVAX supply forecasts are available here:

https://www.gavi.org/sites/default/files/covid/covax/COVAX%20Supply%20Forecast.pdf. We will share the most up-to-date picture during our meeting given the quickly evolving nature of the portfolio.

The pre-read materials are being translated into Arabic, French, Russian and Spanish and we hope to be able to share the translated materials with all participants by Wednesday 17 March.

Les documents sont en cours de traduction en arabe, français, russe et espagnol et nous espérons pouvoir partager les documents traduits avec tous les participants le mercredi 17 mars.

Los materiales se están traduciendo al árabe, francés, ruso y español y esperamos poder compartir los materiales traducidos con todos los participantes,
el miercoles 17 de marzo.

В данный момент материалы переводятся на арабский, французский, русский и испанский языки, и мы надеемся, что сможем их предоставить всем участникам завтра, в  среду 17 марта.

تتم ترجمة المواد إلى العربية والفرنسية والروسية والإسبانية ونأمل أن نتمكن من مشاركة المواد المترجمة مع جميع
المشاركين

يوم الأربعاء 17 مارس.

As indicated in previous correspondence we will be using the
Zoom platform for the meeting.

Our “Guidelines for Meeting of COVAX Shareholders Council – March 2021” (attached) contain important information in relation to the following:

Setting up the
Zoom application

Setting up the interpretation

Connecting to the meeting

Taking part in
discussions during the meeting

Zoom application – it is recommended that participants join the meeting using a computer and
download the meeting application well in advance of the meeting so as to enable any potential technical issues to be resolved in a timely manner.

All participants will receive a Zoom webinar invitation via email which will contain a link to join the meeting. The invitation, which will normally be sent out on Monday 15 March, will
come from COVAX Shareholders Council Meeting ([email-masked]).
Please note that for the security of the meeting, links are individual and non-transferable.

For any technical assistance before or during the meeting, kindly contact
[email-masked].

Should you have any other questions please do not hesitate to contact either Joanne Goetz, Head, Governance ([email-masked])
or myself.

Regards

Brenda

Brenda Killen

Director, Governance

Direct: +41 22 909 66 80

Mobile: +41 79 554 57 04

Web:
gavi.org

NOTICE: This email, including any attachments to it, may be confidential and does not create any binding contract on behalf
of Gavi or its partners.

If this email was sent to you in error, please notify the sender immediately by reply e-mail, and please do not use, distribute,
retain, print or copy the e-mail or any attachment.